Kothari Petrochemicals Ltd Q1 FY26 – India’s PIB Monopoly Maker, But Can One-Product Kings Stay Royal?
1. At a Glance
Market Cap: ₹813 Cr. CMP: ₹138. From a 52-week high of ₹250, the stock has crashed ~40%, reminding everyone that “debt-free + monopoly” does not mean “forever multibagger.” Sales in FY25 were ₹625 Cr with PAT ₹64 Cr. In Q1 FY26, revenue clocked ₹161 Cr (+10.9% YoY), PAT ₹17.6 Cr (–9.2% YoY). EPS TTM: ₹10.9, P/E: 12.7 vs industry 19. ROE: 23.8%, ROCE: 30%—sexy margins on paper, but stock is behaving like a failed Tinder date. Almost debt-free (₹3 Cr debt), but heavy cyclicality risk since raw material comes from CPCL pipelines and Reliance trucks. Dividend yield: 1.27%. Basically, India’s largest PIB (Polyisobutylene) maker is profitable, but the market is treating it like a midlife crisis uncle.
2. Introduction
Kothari Petrochemicals (KPL) is like that one toppers’ batchmate who only studied one subject—scored 100 there, but zero elsewhere. Its one subject? Polyisobutylene (PIB).
Founded in 1990, part of HC Kothari Group, it has become India’s sole significant manufacturer of PIB. With 48,000 TPA licensed capacity, exports to 20 countries, and clients ranging from IOCL to Infineum Singapore, KPL owns this niche.
Problem? PIB is a commodity, tied to oil derivatives. Feedstock prices are linked to Reliance and CPCL, so your EBITDA margin depends on how benevolent Ambani and CPCL feel that month.
The stock fell ~40% last year despite strong ROE. Why? Cyclicality + lack of diversification + market thinking “arre yeh to ek hi product hai.”
So the big Q: can KPL diversify into high molecular weight PIB and other fancy acronyms to escape single-product syndrome?
3. Business Model – WTF Do They Even Do?
In one line: They make PIB and sell PIB.
PIB is a sticky, viscous polymer used in:
Lube oils (improves viscosity index)
Rubber & plastics (makes things flexible)
Paints & adhesives (adds durability)
Food packaging (thanks to USFDA license)
Product lineup sounds like a JEE coaching batch: KVIS-10, KVIS-20, KVIS-30, KVIS-100, KVIS-150, KVIS-200, PIB-R01.
Revenue model:
Contracts/tenders (prices linked to LPG/naphtha → margin cushion)
Spot market sales (monthly price reset after Reliance/CPCL fix their feedstock rates)
Export: 26%, Domestic: 74%. Clientele includes Lubrizol, IOCL, HPCL, Infineum Singapore. Top 5 customers = 39% of revenue → high concentration risk.
Question: Would you bet on a one-product company if it had monopoly status? Or do you prefer diversified players like Supreme Petrochem?
4. Financials Overview
Source table
Metric
Latest Qtr (Q1 FY26)
Same Qtr LY
Prev Qtr
YoY %
QoQ %
Revenue
₹161 Cr
₹145 Cr
₹153 Cr
+10.9%
+5.2%
EBITDA
₹23 Cr
₹18 Cr
₹23 Cr
+27.8%
0.0%
PAT
₹17.6 Cr
₹19.4 Cr
₹17 Cr
–9.2%
+3.5%
EPS (₹)
2.99
3.29
2.94
–9.2%
+1.7%
Commentary: Sales and EBITDA are steady, but PAT slipped due to higher tax. EPS annualized ~₹12 → P/E ~11–12. Looks cheap, but the stock is cheap for a reason—commodity valuation discount.
